Search
for
Sort by
Research 931–960 of 1000+
- Drugs and Androgenetic Alopecia: What to look out for
- Real‐life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24‐week Italian study
- “From evidence to practice” – Insights from the multidisciplinary team on the optimal integration of GLP‐1 receptor agonists in obesity management services
- Alopecia areata exhibits cutaneous and systemic OX40 activation across atopic backgrounds
- Current Protocols: Alopecia Areata Mouse Models for Drug Efficacy and Mechanism Studies
- Central serous chorioretinopathy after scalp and eyebrow intralesional triamcinolone acetonide injections: Report of two cases
- Characterization of scalp, eyelash and eyebrow hair regrowth in patients with severe alopecia areata randomized to placebo in brave AA1 and brave AA2 trials
- Real‐world effectiveness and safety of tofacitinib for alopecia areata: A retrospective cohort study of 202 patients
- BAYONET trial: staged combination with encorafenib, binimetinib, plus cetuximab following encorafenib plus cetuximab for BRAF V600E-mutant metastatic colorectal cancer
- Gene-Environment Interaction Between <i>CYP1B1</i> and Oral Contraception on Frontal Fibrosing Alopecia
- Determining meaningful thresholds for evaluating treatment efficacy in patients with alopecia areata
- Scalp trauma in lichen planopilaris: Case reports of disease progression from fire fighter helmet use
- Wigs and Alopecia Areata: Psychosocial Impact and Economic Considerations
- Lichen planopilaris in 24 African American women
- Validation of alopecia coding in US claims data among women of childbearing age
- The Epidemiology of Hospital-Treated Alopecia Areata in Denmark, 1995–2016
- Correlating Cicatricial Alopecia and Cardiovascular Risk: Emerging Insights
- Combating “Dread Shed”: The Impact of Overlapping Topical and Oral Minoxidil on Temporary Hair Shedding During Oral Minoxidil Initiation
- Characteristics and Management of Patients with Alopecia Areata and Selected Comorbid Conditions: Results from a Survey in Five European Countries
- Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
- Clinical and sociodemographic features of alopecia areata in five Colombian cities: an analysis of the RENAAC registry
- Recomendaciones sobre el manejo clínico de la alopecia androgénica: un documento de consenso del Grupo Español de Tricología de la Academia Española de Dermatología y Venereología
- Insight into Recent Advances in Degrading Androgen Receptor for Castration-Resistant Prostate Cancer
- PCSK9: From Nature’s Loss to Patient’s Gain
- Visualizing Severity of Alopecia Tool (SALT) scores in the clinical setting using patient images from a clinical trial
- Patient satisfaction with multidisciplinary shared medical appointments for alopecia areata and frontal fibrosing alopecia
- Estimating the burden of skin diseases using patient‐reported daily time trade‐off as a measure of disease impact and unmet needs
- Minoxidil: effectiveness and prospects for use in the treatment of androgenetic alopecia
- Treatment preferences of adults and adolescents with alopecia areata: A discrete choice experiment
- Degree of Alignment Between Japanese Patients and Physicians on Alopecia Areata Disease Severity and Treatment Satisfaction: A Real-World Survey